Text this: WCN25-1188 THE USEFULNESS OF URINARY N-ACETYL- β-D-GLUCOSAMINIDASE-CREATININE RATIO AS THE BIOMARKER TO DECIDE LONG-TERM USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR IN DIABETIC KIDNEY DISEASE